Uzbekistan and Denmark discussed pharmaceutical regulation

Uzbekistan and Denmark held talks on pharmaceutical regulation.

Tashkent, Uzbekistan (UzDaily.uz) —

Representatives of Uzbekistan and Denmark discussed potential areas of cooperation in pharmaceutical regulation. A videoconference attended by staff from the Center for Pharmaceutical Safety, the Danish Medicines Agency (DKMA), and the Embassy of Uzbekistan in Sweden took place on August 11, 2026, according to the Center for Pharmaceutical Safety.

During the meeting, the Uzbek side presented an overview of the Center's activities, competencies, and key areas of work.

Specifically, the discussion covered topics such as state registration and examination of medicines, pharmacovigilance, drug quality control, laboratory activities, ensuring the safety of pharmaceutical products, and the implementation of international standards.

Participants discussed the importance of international standards and modern approaches to pharmaceutical regulation, the exchange of experience between regulatory bodies, and professional development. The Danish Medicines Agency is the Danish government agency responsible for regulating medicines and medical devices. Its functions include drug registration, licensing and inspection of pharmaceutical companies, pharmacovigilance, clinical trials, and medical device safety monitoring.

The meeting focused on the practical aspects of bilateral cooperation. Specifically, the parties discussed prospects for direct interaction between experts, sharing experience in regulatory practice, and organizing training seminars and professional development programs.

The possibility of implementing joint projects aimed at developing the professional potential of pharmaceutical industry specialists was also discussed.